Hodpro 50mg Capsule contains Procarbazine, an antineoplastic agent used primarily in the treatment of Hodgkin's lymphoma and certain types of brain tumors. Procarbazine acts as an alkylating agent, interfering with DNA, RNA, and protein synthesis, thereby inhibiting the growth and proliferation of malignant cells. Hodpro is administered orally and is typically prescribed as part of combination chemotherapy regimens. The dosage and duration of treatment depend on the specific condition being treated, patient response, and tolerance. Common side effects may include nausea, vomiting, myelosuppression, and neurotoxicity; therefore, regular monitoring of blood counts and neurological status is recommended during therapy. Patients should be advised to avoid alcohol consumption due to the potential for disulfiram-like reactions. Procarbazine is contraindicated in patients with hypersensitivity to the drug and should be used cautiously in those with impaired hepatic or renal function. Due to its teratogenic potential, effective contraception is advised during treatment. Hodpro 50mg Capsule should be stored at room temperature, away from moisture and light, and kept out of reach of children. This medication must be prescribed and administered under the supervision of a qualified healthcare professional experienced in oncology treatment.